(MA13) Lyxor EuroMTS Highest - Ratings and Ratios
Exchange: PA •
Country: France •
Currency: EUR •
Type: Etf •
ISIN: LU1829219556
Government, Bonds, Euro, Investments
Description: MA13 Lyxor EuroMTS Highest
URL: http://www.amundi.com Index: Morningstar EZN 1-3 Yr Tsy Bd GR EUR
Additional Sources for MA13 ETF
MA13 ETF Overview
| Market Cap in USD | 328m |
| Category | EUR Government Bond - Short Term |
| TER | 0.16% |
| IPO / Inception | 2018-11-08 |
MA13 ETF Ratings
| Growth Rating | 16.1 |
| Fundamental | - |
| Dividend Rating | 0.0 |
| Rel. Strength | 5.86 |
| Analysts | - |
| Fair Price Momentum | 94.00 EUR |
| Fair Price DCF | - |
MA13 Dividends
Currently no dividends paidMA13 Growth Ratios
| Growth Correlation 3m | 76.6% |
| Growth Correlation 12m | 88.1% |
| Growth Correlation 5y | -15% |
| CAGR 5y | 0.03% |
| CAGR/Max DD 5y | 0.00 |
| Sharpe Ratio 12m | -1.57 |
| Alpha | 2.22 |
| Beta | -0.023 |
| Volatility | 0.74% |
| Current Volume | 0.1k |
| Average Volume 20d | 0.1k |
What is the price of MA13 shares?
As of July 05, 2025, the stock is trading at EUR 100.82 with a total of 53 shares traded.
Over the past week, the price has changed by +0.09%, over one month by +0.13%, over three months by +0.38% and over the past year by +3.96%.
As of July 05, 2025, the stock is trading at EUR 100.82 with a total of 53 shares traded.
Over the past week, the price has changed by +0.09%, over one month by +0.13%, over three months by +0.38% and over the past year by +3.96%.
Is Lyxor EuroMTS Highest a good stock to buy?
Neither. Based on ValueRay´s Analyses, Lyxor EuroMTS Highest is currently (July 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 16.09 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of MA13 is around 94.00 EUR . This means that MA13 is currently overvalued and has a potential downside of -6.76%.
Neither. Based on ValueRay´s Analyses, Lyxor EuroMTS Highest is currently (July 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 16.09 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of MA13 is around 94.00 EUR . This means that MA13 is currently overvalued and has a potential downside of -6.76%.
Is MA13 a buy, sell or hold?
Lyxor EuroMTS Highest has no consensus analysts rating.
Lyxor EuroMTS Highest has no consensus analysts rating.
What are the forecasts for MA13 share price target?
According to our own proprietary Forecast Model, MA13 Lyxor EuroMTS Highest will be worth about 101.5 in July 2026. The stock is currently trading at 100.82. This means that the stock has a potential upside of +0.69%.
According to our own proprietary Forecast Model, MA13 Lyxor EuroMTS Highest will be worth about 101.5 in July 2026. The stock is currently trading at 100.82. This means that the stock has a potential upside of +0.69%.
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 101.5 | 0.7% |